![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication May 4, 2005.
Revised August 4, 2005.
Accepted for publication August 4, 2005.
We previously showed that the function of renal Multidrug resistance protein 2 (Mrp2; Abcc2) is reduced by endothelin-1 (ET-1) signaling through an ETB receptor, NOS, cGMP and protein kinase C and that this pathway was activated by several nephrotoxicants (Masereeuw et al., 2000; Notenboom et al., 2002; Notenboom et al., 2004; Terlouw et al., 2001). Here we determined the long-term effects on Mrp2-mediated transport (luminal fluorescein methotrexate accumulation) of short-term (30 min) exposure to ET-1 and the aminoglycoside antibiotic, gentamicin. Our data show that over the 3h following exposure proximal tubules recovered fully from the initial decrease in Mrp2-mediated transport and that transport activity was not changed 9h later. However, 24h after exposure, luminal accumulation of an Mrp2 substrate had increased by 50%. Increased transport at 24h was accompanied by an increased transporter protein content of the luminal plasma membrane as measured by immunostaining. Blocking ET-1 signaling at the ETB receptor or downstream at NOS or guanylyl cyclase abolished both stimulation of transport and increased transporter expression. Thus, regardless of whether signaling was initiated by a short exposure to ET-1 or to a nephrotoxicant, the time course of Mrp2 response to ETB signaling was the same and was multiphasic. Finally, when tubules were exposed to gentamicin for 30 min and removed to gentamicin-free medium for 24h they were less sensitive to acute gentamicin toxicity than paired controls not initially exposed to the drug. Thus, short-term exposure to ET-1 or gentamicin resulted in long-term protection against a second insult.
Key words:
endothelin signaling, gentamicin, multidrug resistance protein 2, nephrotoxicity, renal drug transport, transport protein expression
This article has been cited by other articles:
![]() |
V. Reichel, R. Masereeuw, J. J. M. W. van den Heuvel, D. S. Miller, and G. Fricker Transport of a fluorescent cAMP analog in teleost proximal tubules Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2382 - R2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Miller, J. R. Shaw, C. R. Stanton, R. Barnaby, K. H. Karlson, J. W. Hamilton, and B. A. Stanton MRP2 and Acquired Tolerance to Inorganic Arsenic in the Kidney of Killifish (Fundulus heteroclitus) Toxicol. Sci., May 1, 2007; 97(1): 103 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Wever, R. Masereeuw, D. S. Miller, X. M. Hang, and G. Flik Endothelin and calciotropic hormones share regulatory pathways in multidrug resistance protein 2-mediated transport Am J Physiol Renal Physiol, January 1, 2007; 292(1): F38 - F46. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Notenboom, A. C. Wouterse, B. Peters, L. H. Kuik, S. Heemskerk, F. G. M. Russel, and R. Masereeuw Increased Apical Insertion of the Multidrug Resistance Protein 2 (MRP2/ABCC2) in Renal Proximal Tubules following Gentamicin Exposure J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1194 - 1202. [Abstract] [Full Text] [PDF] |
||||